BIOMED Wytwornia Surowic i Szczepionek Sp zoo (BML) - Financial and Strategic SWOT Analysis Review

Summary

Biomed Wytwornia Surowic i Szczepionek Sp zoo (Biomed) is a pharmaceutical company that manufactures and markets medicinal products, medical devices and laboratory reagents. The companys prescription drugs include thrombin, human gamma globulin, gastrotrombina, bio trombina, gamma anty-d 150, distreptaza, histaglobulin and antitubercle vaccine. Biomed offers medicinal products such as lakcid forte capsules, biohemoril, lakcid capsules, bioglicerol and biospasmil. The company offers vaccines for typhus, dysenter, rabies, typhoid, pertussis and scarlet fever, influenza, diphtheria-tetanus, polio vaccine, among others. Biomed markets its products through its network of distributors. The company also conducts clinical trials in cooperation with research facilities and medical centres. Biomed is headquartered in Lublin, Poland.

This comprehensive SWOT profile of BIOMED Wytwornia Surowic i Szczepionek Sp zoo provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalDatas Profile on Demand service, covering over 50,000 of the worlds leading companies. Once purchased, GlobalDatas highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of BIOMED Wytwornia Surowic i Szczepionek Sp zoo including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents

Section 1 - About the Company

BIOMED Wytwornia Surowic i Szczepionek Sp zoo - Key Information
BIOMED Wytwornia Surowic i Szczepionek Sp zoo - Overview
BIOMED Wytwornia Surowic i Szczepionek Sp zoo - Key Employees
BIOMED Wytwornia Surowic i Szczepionek Sp zoo - Key Employee Biographies
BIOMED Wytwornia Surowic i Szczepionek Sp zoo - Key Operational Heads
BIOMED Wytwornia Surowic i Szczepionek Sp zoo - Major Products and Services
BIOMED Wytwornia Surowic i Szczepionek Sp zoo - History
BIOMED Wytwornia Surowic i Szczepionek Sp zoo - Company Statement
BIOMED Wytwornia Surowic i Szczepionek Sp zoo - Locations And Subsidiaries
BIOMED Wytwornia Surowic i Szczepionek Sp zoo
Head Office
Other Locations & Subsidiaries

Section 2 - Company Analysis

BIOMED Wytwornia Surowic i Szczepionek Sp zoo - Business Description
BIOMED Wytwornia Surowic i Szczepionek Sp zoo - Corporate Strategy
BIOMED Wytwornia Surowic i Szczepionek Sp zoo - SWOT Analysis
SWOT Analysis - Overview
BIOMED Wytwornia Surowic i Szczepionek Sp zoo - Strengths
BIOMED Wytwornia Surowic i Szczepionek Sp zoo - Weaknesses
BIOMED Wytwornia Surowic i Szczepionek Sp zoo - Opportunities
BIOMED Wytwornia Surowic i Szczepionek Sp zoo - Threats
BIOMED Wytwornia Surowic i Szczepionek Sp zoo - Key Competitors

Section 3 - Company Financial Performance Charts

BIOMED Wytwornia Surowic i Szczepionek Sp zoo - Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

Section 4 - Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer


Note*: Some sections may be missing if data is unavailable for the company

List Of Tables

List of Tables

BIOMED Wytwornia Surowic i Szczepionek Sp zoo, Key Information
BIOMED Wytwornia Surowic i Szczepionek Sp zoo, Key Ratios
BIOMED Wytwornia Surowic i Szczepionek Sp zoo, Share Data
BIOMED Wytwornia Surowic i Szczepionek Sp zoo, Major Products and Services
BIOMED Wytwornia Surowic i Szczepionek Sp zoo, History
BIOMED Wytwornia Surowic i Szczepionek Sp zoo, Key Employees
BIOMED Wytwornia Surowic i Szczepionek Sp zoo, Key Employee Biographies
BIOMED Wytwornia Surowic i Szczepionek Sp zoo, Key Operational Heads
BIOMED Wytwornia Surowic i Szczepionek Sp zoo, Other Locations
BIOMED Wytwornia Surowic i Szczepionek Sp zoo, Subsidiaries
BIOMED Wytwornia Surowic i Szczepionek Sp zoo, Key Competitors
BIOMED Wytwornia Surowic i Szczepionek Sp zoo, SWOT Analysis
BIOMED Wytwornia Surowic i Szczepionek Sp zoo, Ratios based on current share price
BIOMED Wytwornia Surowic i Szczepionek Sp zoo, Annual Ratios
BIOMED Wytwornia Surowic i Szczepionek Sp zoo, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

List of Figures

BIOMED Wytwornia Surowic i Szczepionek Sp zoo, Performance Chart
BIOMED Wytwornia Surowic i Szczepionek Sp zoo, Ratio Charts

Global Bovine-based Collagen for Biomedical Applications Market Research Report 2015-2027 of Major Types, Applications and Competitive Vendors in Top Regions and Countries

The Global market for Bovine-based Collagen for Biomedical Applications is estimated to grow at a CAGR of roughly X.X% in the next 8 years, and will reach USD X.X million

USD 2960 View Report

Global Biomedical Textiles Market Status and Forecast Analysis 2016-2025

This report studies the Biomedical Textiles market status and outlook of global and major regions, from angles of manufacturers, regions, product types and end industries; this report analyzes the top

USD 2800 View Report

BIOMED Wytwornia Surowic i Szczepionek Sp z oo (BML) - Financial and Strategic SWOT Analysis Review

BIOMED Wytwornia Surowic i Szczepionek Sp z oo (Biomed) manufactures and markets medicinal products, medical devices and laboratory reagents. The companys prescription medicines include thrombin, human gamma globulin, gastrotrombina, bio

USD 300 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available